Patents by Inventor Tomi Streng

Tomi Streng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10780063
    Abstract: This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: September 22, 2020
    Assignee: HORMOS MEDICAL LTD.
    Inventors: Risto Santti, Tomi Streng
  • Publication number: 20180256513
    Abstract: This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: May 8, 2018
    Publication date: September 13, 2018
    Inventors: Risto Santti, Tomi Streng
  • Patent number: 9993442
    Abstract: This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 21, 2015
    Date of Patent: June 12, 2018
    Assignee: HORMOS MEDICAL LTD.
    Inventors: Risto Santti, Tomi Streng
  • Publication number: 20150352059
    Abstract: This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 21, 2015
    Publication date: December 10, 2015
    Inventors: Risto Santti, Tomi Streng
  • Patent number: 9114106
    Abstract: This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: January 15, 2015
    Date of Patent: August 25, 2015
    Assignee: HORMOS MEDICAL LTD.
    Inventors: Risto Santti, Tomi Streng
  • Publication number: 20150126613
    Abstract: This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: January 15, 2015
    Publication date: May 7, 2015
    Inventors: Risto Santti, Tomi Streng
  • Patent number: 8962693
    Abstract: This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 19, 2013
    Date of Patent: February 24, 2015
    Assignee: Hormos Medical Ltd.
    Inventors: Risto Santti, Tomi Streng
  • Publication number: 20130345313
    Abstract: This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 19, 2013
    Publication date: December 26, 2013
    Applicant: Hormos Medical Corporation
    Inventors: Risto Santti, Tomi Streng
  • Publication number: 20100305158
    Abstract: This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: August 16, 2010
    Publication date: December 2, 2010
    Inventors: Risto Santti, Tomi Streng
  • Patent number: 7825107
    Abstract: A method for treatment or prevention of chronic nonbacterial prostatitis in individuals without urethral sphincter dysfunction, comprises administering an effective amount of (i) a selective estrogen receptor modulator (SERM) having estrogen antagonist effect in the prostate, (ii) an aromatase inhibitor, and/or (iii) an antiestrogen.
    Type: Grant
    Filed: May 22, 2007
    Date of Patent: November 2, 2010
    Assignee: Hormos Medical Ltd.
    Inventors: Risto Santti, Tomi Streng, Jenni Bernoulli, Emrah Yatkin
  • Patent number: 7345073
    Abstract: The present invention relates to a method and pharmaceutical composition for the treatment of male individuals suffering from cryptorchidism comprising administering to said individuals an effective amount of an aromatase inhibitor, preferably finrozole.
    Type: Grant
    Filed: October 7, 2005
    Date of Patent: March 18, 2008
    Assignee: Hormos Medical Ltd.
    Inventors: Tomi Streng, Sari Mäkelä, Risto Santti, Matti Poutanen, Xiangdong Li
  • Publication number: 20080021111
    Abstract: A method for treatment or prevention of chronic nonbacterial prostatitis in individuals without urethral sphincter dysfunction, comprises administering an effective amount of (i) a selective estrogen receptor modulator (SERM) having estrogen antagonist effect in the prostate, (ii) an aromatase inhibitor, and/or (iii) an antiestrogen.
    Type: Application
    Filed: May 22, 2007
    Publication date: January 24, 2008
    Applicant: Hormos Medical Ltd.
    Inventors: Risto Santti, Tomi Streng, Jenni Bernoulli, Emrah Yatkin
  • Publication number: 20060030570
    Abstract: The present invention relates to a method and pharmaceutical composition for the treatment of male individuals suffering from cryptorchidism comprising administering to said individuals an effective amount of an aromatase inhibitor, preferably finrozole.
    Type: Application
    Filed: October 7, 2005
    Publication date: February 9, 2006
    Inventors: Tomi Streng, Sari Makela, Risto Santti, Matti Poutanen, Xiandong Li
  • Patent number: 6931276
    Abstract: Method and device for the sensing of the electromyographic activity of an individual's bladder detrusor muscle, where an elongated electrode is inserted through the individual's urethra, so that the proximal end of the electrode becomes positioned in the bladder, and the bladder is charged with a fluid having electrical conductivity, and the electrical potential of the detrusor muscle, mediated by the fluid, is sensed by the electrode.
    Type: Grant
    Filed: April 29, 2002
    Date of Patent: August 16, 2005
    Inventors: Tomi Streng, Antti Talo, Risto Santti
  • Publication number: 20040248989
    Abstract: This invention concerns a method for treatment or prevention of lower urinary tract symptoms with or without pelvic pain in an individual, said method comprising administering to the individual an effective amount of a selective estrogen receptor modulator, or an isomer, isomer mixture or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: June 5, 2003
    Publication date: December 9, 2004
    Inventors: Risto Santti, Tomi Streng
  • Publication number: 20040157808
    Abstract: The present invention relates to a method and pharmaceutical composition for the treatment of male individuals suffering from cryptorchidism comprising administering to said individuals an effective amount of an aromatase inhibitor, preferably finrozole.
    Type: Application
    Filed: February 7, 2003
    Publication date: August 12, 2004
    Inventors: Tomi Streng, Sari Makela, Risto Santti, Matti Poutanen, Xiandong Li
  • Publication number: 20030204149
    Abstract: The present invention concerns a method for the sensing of the electromyographic activity of an individual's bladder detrusor muscle, wherein
    Type: Application
    Filed: April 29, 2002
    Publication date: October 30, 2003
    Inventors: Tomi Streng, Antti Talo, Risto Santti
  • Patent number: 6316431
    Abstract: This invention relates to the use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ration (DATER) as well as to a method for the treatment of detrusor urethral sphincter dyssnergia (DUSD) in men.
    Type: Grant
    Filed: September 19, 2000
    Date of Patent: November 13, 2001
    Assignee: Hormors Medical Oy Ltd.
    Inventors: Risto Santti, Antti Talo, Tomi Streng, Kaija Halonen, Lauri Kangas, Risto Lammintausta
  • Patent number: 5972921
    Abstract: The invention relates to a method for the treatment of detrusor urethral sphincter dyssynergia in men, said method comprising administering to the patient an effective amount of an aromatase inhibitor. The invention also concerns a method for the treatment of decreased androgen to estrogen ratio in men, said method comprising administering to the patient an effective amount of an aromatase inhibitor.
    Type: Grant
    Filed: December 12, 1997
    Date of Patent: October 26, 1999
    Assignee: Hormos Medical Oy Ltd.
    Inventors: Risto Santti, Antti Talo, Tomi Streng, Kaija Halonen, Lauri Kangas, Risto Lammintausta